{"name":"Cynata Therapeutics Limited","slug":"cynata-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNelhrcjExd2J4Zk42Si1tOXpfTFg4WWxGVTVDeVZpS2t5NlNEZmF4bzJmckVTZ2owS21nX0l4d3RWeWJwYkRHcjYxNVk0VEFyYmVSeWt4TWYxRFc1cWljRWVtR3M1LS15VHRZMU54MzFEQmZab0lLNE95b2pFR1ZKNVRKRzNCMDBQOUkxRGpyMGR3U1hkMktvajdaM0t3M3ZaNkwteQ?oc=5","date":"2026-03-30","type":"trial","source":"PharmaDispatch","summary":"Cynata reaches crucial milestone as Phase 2 trial moves toward results - PharmaDispatch","headline":"Cynata reaches crucial milestone as Phase 2 trial moves toward results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-03-26","type":"pipeline","source":"The Australian","summary":"Japan’s iPSC milestone lifts Cynata focus - The Australian","headline":"Japan’s iPSC milestone lifts Cynata focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQeTRzN3otTURHcC1tdDUtWE5FWE5IR3l2dUpxUk55R09ZWUtkTFZXVHh2cjRaeVRSYUdtSVJWSmU1QVlrR2pwa0VmSkx6bXNoa3p3cUZoNWlNcVZyM29ZN2Z0WXdWZ0s4bFdoVW1KVFc0ZVFQbWNkNmp5b1lYUHhCNVhJZFV5a2s0T19FNEg1RnRwRWtRVmp6d0dTdw?oc=5","date":"2026-03-24","type":"pipeline","source":"openPR.com","summary":"Osteoarthritis Pipeline Witnesses Strong Expansion with 100+ - openPR.com","headline":"Osteoarthritis Pipeline Witnesses Strong Expansion with 100+","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-26","type":"earnings","source":"simplywall.st","summary":"When Will Cynata Therapeutics Limited (ASX:CYP) Turn A Profit? - simplywall.st","headline":"When Will Cynata Therapeutics Limited (ASX:CYP) Turn A Profit?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPaUpjZWVBaHRGWXRIZ3Zibk1KT0pHaTNlUFd2aVhvaHZmSGFBcVBPeDVIdGQ1M2oyRVNWQ21wSVNqOXZseVNTX1lwU0lZcE9tbFVKVHlvVTUybzFiOFdHc1lialNhYXVmTHNzTHFRZGxRS1N3M2UzdUNDeXZvR3ZwTGJkdk1iaXJSWkVzT3NVZkUzWmJBM00tZEtuclVNMk52NUJqN1RGbjhCMjh1VmRRUmMtVElCZGtFZVI0UHd2bW81NmZjR3ZXZkZJY0JhWUtQZ0ZsbnpIbW11Q3BtQkhJeVhlQ1gwNFFlT2pzTFdZbVhJV3hkQTFVUktYQWdmSUJTSzdvbUFYT1Y1aW5UUHdEUW1jNy0wRU9Zb1R2MzJYNHZaeDhQODlYQkRDUG9kcExoa0dzWUxESktqY0hEMkZFQTVHQzJ2aGdKdURJUzNhMzA?oc=5","date":"2025-10-09","type":"regulatory","source":"Business Wire","summary":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040 - ResearchAndMarkets.com - Business Wire","headline":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldw","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNQmJfaGVoclZTWlZZeEYtVGhYM01UZDBhZ2tWUnk5N1Z3aVRLY1dsLUJXOXdrbURHb3YxdXYwbnVuN2s2dFdWUjZPWU95WDE3b3ZMcXdSWF94UjNuWmktMUMwRHVCdDV6UlFwNm4wQ3RsX2tFczVSOGRqbnJiUHphUXlWZHV4ZjRjbnlDbFJNTUNkT2JqQWVnZlFLMlpqY0JjRGZN?oc=5","date":"2025-02-26","type":"pipeline","source":"Stockhead","summary":"Biocurious: With Mayne Pharmaceuticals under takeover offer, who’s next? - Stockhead","headline":"Biocurious: With Mayne Pharmaceuticals under takeover offer, who’s next?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBobUtuTGJ4UVNfQmdRSkNjQ0RJaHZxZmdJSmNUTXpYMlMyTURIZXQwWGdrb1RrNzlwWnVyUmxPR2Iwazk5QkY4UXFEajBjbF9nT0FVdHo0UzktenE4dk5n0gFkQVVfeXFMTXFVZEE4akZyRmNENG5YWkFxWlB1WjgwQTFoYlRlcXRnNmJ3X20xZExwWkdWN1JacldjNm1QdVFOTU9SZTVZb2xMZzNKUUdvQWJkbzdLQ3pXbFdyd1g1NDJnYWY5SQ?oc=5","date":"2024-12-06","type":"pipeline","source":"BioInformant","summary":"Cynata Introduces Critical Innovation into MSC Manufacturing - BioInformant","headline":"Cynata Introduces Critical Innovation into MSC Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxPejRGZWJpTmZNNWVJdm9YTHBrVk5xakRVV1NsbVhjQUxiVm9rbTc5OXBkMUpfVmRGMW9MOFpCcUliakR0emU4UjBrWUNIZWZQRlhoVEU1ODhHUWcxOGdkY3hIektmaGRoVDJMX1hTSllXTnBjbi1qYlE3cHY5QTN1SW1VcHpnc1NJbDdpcElkZW5JbmNiZ24taE5sVWRWZ0VIVkNYOHdvSTZXYVpKOXZDSFpNLVFlOEZJaFFxQkFLckM4WlA1aTJwT01XcW4xREsya0JYT1JJcHRHYmJwMExJNzRmeEYzZU1kTVNNdm5kVUlzN2xvcEJpWG8wNnBoU000N2Z4N2FvSU5pY29zeVFHNkVMbUU3RzhSbFh0a0hQNVE0eVFOQk4wdjBZYlg?oc=5","date":"2024-08-15","type":"pipeline","source":"GlobeNewswire","summary":"Global Non-Steroidal Anti-Inflammatory Drugs Market is - GlobeNewswire","headline":"Global Non-Steroidal Anti-Inflammatory Drugs Market is","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5xMEpmNDNnb0wtX1RhdVZ5NVFyTFY4RkhnWDZndWtGUDRVWmlDUVBYTDV2X2k5R1VETy1PamhnYm9iVmdQZHh4ZVBZdmVVckpHTHZKcnhMSUNtR3PSAWBBVV95cUxPaUJXTVRPc2RxYzJ6UHZpV2RLcUE5TmhPS1VLdXdDMG1PZG01WThMOFRaVjROcnNiakhqZHVWWjgtOXpKX3JvYlZUTFBucm5ITHJ2YUFuMHZEbGE5WWZJc0k?oc=5","date":"2024-07-09","type":"pipeline","source":"BioInformant","summary":"Behind the Scenes at Cynata Therapeutics with Dr. Ross Macdonald - BioInformant","headline":"Behind the Scenes at Cynata Therapeutics with Dr. Ross Macdonald","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CQk9pN1VmVUpkRXBkVVJrbEtEeWpmdDhXNmticDdVQUJBT2pRd1BaVGxWNHc5TUJjbG55QXYzNF9IUVE1QVRtUFRGd20zRXRTeFlTWk8yUVlpblZGbXQw?oc=5","date":"2024-05-22","type":"pipeline","source":"Nature","summary":"Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease - Nature","headline":"Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host dise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE91V2VKV05uLUFoZVBrYVhLd2lySXh1d1NrZ1haekRGM0c4Z2p6OUduRVZFdklCeFJ3UlVxRHFyQkdCR3JJU2ZpQ0xuS3lITFU5SDRxOEVva016VFZDS2tyZXBFN3VhM2xwaG5kZXhLdkprUGw5Y1BmTQ?oc=5","date":"2023-11-15","type":"pipeline","source":"pharmexec.com","summary":"2024 Pipeline Report: First-World Focus - pharmexec.com","headline":"2024 Pipeline Report: First-World Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNbDA1V05mQy1uUnFrRXIyRmoxNFJVRmVBbG9yRHpuc2pEUmpQTS1teTVBNDRvc0RHTF8tbUZvR2lkNWsxY2FzTjMtX3g2NGQwdDExaWJWeDVKNXRYM3VZaXV3SEs1eEs4VXhURnlJUFVXQlVvbUtIeVo5eTJIUl9pZTlvVjk4dTYtQzhoT3JnT0RjaW1SYVlwelIxV1FidEhBU2g5STh3S3FESUFHenVmeDRaQ0ZuOGpjcFphSVA2WVQ3NjhfaFZNRUM0MVJ1TkVVNW4zU1lIWllrZ1lUeDM0?oc=5","date":"2020-01-24","type":"pipeline","source":"Proactive financial news","summary":"Cynata Therapeutics to talk stem cell therapies at Proactive’s CEO Sessions - Proactive financial news","headline":"Cynata Therapeutics to talk stem cell therapies at Proactive’s CEO Sessions","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}